Pentarlandir (SNB011) / SyneuRx  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pentarlandir (SNB011) / SyneuRx
NCT04911777: Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19

Recruiting
2
90
US
Pentarlandir™ UPPTA, Placebo
SyneuRx International (Taiwan) Corp
Coronavirus Disease 2019
12/21
03/22

Download Options